16 June 2025
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
Banco de Sabadell, S.A.
Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 13 May 2025, Morgan Stanley Europe SE (contact: Morgan Stanley Debt Syndicate - Florian Hessel; telephone: +49 69 2166 1287) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014), including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.
Securities
|
Issuer: |
Banco de Sabadell, S.A. |
|
Guarantor(s) (if any): |
N/A |
|
Aggregate nominal amount: |
EUR 1,000,000,000 |
|
Description: |
Perpetual Non-Cumulative Contingent Convertible Additional Tier 1 Preferred Securities |
|
ISIN: |
XS3037646661 |
|
Offer price: |
100% |
Stabilisation
|
Stabilisation Manager(s): |
Morgan Stanley Europe SE Banco de Sabadell, S.A. Barclays Bank Ireland PLC Crédit Agricole Corporate and Investment Bank Deutsche Bank AG Goldman Sachs Bank Europe SE Société Générale |
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
